These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 18233953)

  • 21. Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators.
    Norling LV; Ly L; Dalli J
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):145-152. PubMed ID: 28002074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel lipid mediator PD1
    Hansen TV; Dalli J; Serhan CN
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():103-110. PubMed ID: 28602942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.
    Serhan CN; Dalli J; Colas RA; Winkler JW; Chiang N
    Biochim Biophys Acta; 2015 Apr; 1851(4):397-413. PubMed ID: 25139562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
    Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
    Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):157-63. PubMed ID: 19008087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing.
    Norling LV; Spite M; Yang R; Flower RJ; Perretti M; Serhan CN
    J Immunol; 2011 May; 186(10):5543-7. PubMed ID: 21460209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins.
    Serhan CN
    Curr Opin Clin Nutr Metab Care; 2005 Mar; 8(2):115-21. PubMed ID: 15716788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids.
    Zhang MJ; Spite M
    Annu Rev Nutr; 2012 Aug; 32():203-27. PubMed ID: 22404117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.
    Spite M; Serhan CN
    Circ Res; 2010 Nov; 107(10):1170-84. PubMed ID: 21071715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoxins: resolutionary road.
    Maderna P; Godson C
    Br J Pharmacol; 2009 Oct; 158(4):947-59. PubMed ID: 19785661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
    Serhan CN; Gotlinger K; Hong S; Arita M
    Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):155-72. PubMed ID: 15290791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of lipoxins and resolvins in human leukocytes.
    Kahnt AS; Schebb NH; Steinhilber D
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators.
    Chiang N; Serhan CN
    Methods Mol Biol; 2006; 341():227-50. PubMed ID: 16799203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biosynthetic pathways of the protectins.
    Stenvik Haatveit Å; Hansen TV
    Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106787. PubMed ID: 37806439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
    Nowak JZ
    Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.
    Serhan CN; Chiang N; Van Dyke TE
    Nat Rev Immunol; 2008 May; 8(5):349-61. PubMed ID: 18437155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis.
    Souza PR; Norling LV
    Eur J Pharmacol; 2016 Aug; 785():165-173. PubMed ID: 26165764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoxins and resolvins in inflammatory bowel disease.
    Weylandt KH; Kang JX; Wiedenmann B; Baumgart DC
    Inflamm Bowel Dis; 2007 Jun; 13(6):797-9. PubMed ID: 17262807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators.
    Oh SF; Vickery TW; Serhan CN
    Biochim Biophys Acta; 2011 Nov; 1811(11):737-47. PubMed ID: 21712098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.